The frequent discovery of new disease-causing strains has resulted in increased innovation in drug designing, development, and improved treatments, and protein therapeutics is one of them. A new report “Global Protein Therapeutics Market Analysis” by RNCOS, the leading market research company, provides an in-depth research on the global protein therapeutics market.
‘Therapeutic Proteins’ are actually the proteins engineered in laboratory for pharmaceutical use. As the treatment is highly effective, its market is growing by leaps and bounds. The report says that the estimated value of protein therapeutics market in 2006 was over US$ 57 Billion, a straight growth of around 13.5% from 2005. The report predicts the global protein therapeutics market to grow at a CAGR of around 12.9% during 2007-2010 and clock about US$ 93 Billion as revenues.
The report has attributed this concrete growth in the protein therapeutics market to the high efficiency and ability of this class of drugs to target a particular disease unlike the traditional pharmaceuticals, increasing frequency of chronic diseases, ageing population, growing penetration of health insurance, advancements in the modes of drug delivery, and new indications for protein therapeutics.
The growing market for protein therapeutics is opening other vistas too for growth. According to the RNCOS report, biogenerics, that is anticipated to emerge as a billion-dollar industry in near future, will be one of the major opportunity areas in the protein therapeutics market.
But the success for protein therapeutics market would not come easy. The report says that certain barriers, like high R&D cost and high failure rate in Phase-3 of clinical trials, remain an inevitable challenge for the protein therapeutics market all around the world. Moreover, complex insurance reimbursement procedures and inconsistent government regulations also threaten the market. However, despite these inhibitors, the market for protein therapeutics is augured to keep growing at a double-digit rate through 2010.
The report “Global Protein Therapeutics Market Analysis” gives the most recent information on the global protein therapeutics market. It evaluates the market thoroughly and analyzes several protein therapeutics (such as Monoclonal Antibodies, Erythropoietin, Interferon etc) used for disease control and prevention, with their market size, areas of application, and future forecast. All the major geographical markets, like the US, Brazil, Germany, Russia, Japan, and India, for various protein therapeutics are discussed in the report.
RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of industry experts who analyze data collected from credible sources. They provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.